Anti-TNF Therapy During the SARS-CoV-2 Pandemic: Friend or Foe?

Asaf Levartovsky; Shomron Ben-Horin

doi:10.1093/ecco-jcc/jjab167

Anti-TNF Therapy During the SARS-CoV-2 Pandemic: Friend or Foe?

Asaf Levartovsky^*, Shomron Ben-Horin

^*Corresponding author for this work

Internal Medicine

Research output: Contribution to journal › Editorial

Original language	English
Pages (from-to)	517
Number of pages	1
Journal	Journal of Crohn's and Colitis
Volume	16
Issue number	4
DOIs	https://doi.org/10.1093/ecco-jcc/jjab167
State	Published - 1 Apr 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1093/ecco-jcc/jjab167

Cite this

@article{aed6257b5ec1463a93bfb7660cb2672b,

title = "Anti-TNF Therapy During the SARS-CoV-2 Pandemic: Friend or Foe?",

author = "Asaf Levartovsky and Shomron Ben-Horin",

year = "2022",

month = apr,

day = "1",

doi = "10.1093/ecco-jcc/jjab167",

language = "אנגלית",

volume = "16",

pages = "517",

journal = "Journal of Crohn's and Colitis",

issn = "1873-9946",

publisher = "Oxford University Press",

number = "4",

}

TY - JOUR

T1 - Anti-TNF Therapy During the SARS-CoV-2 Pandemic

T2 - Friend or Foe?

AU - Levartovsky, Asaf

AU - Ben-Horin, Shomron

PY - 2022/4/1

Y1 - 2022/4/1

UR - http://www.scopus.com/inward/record.url?scp=85130001373&partnerID=8YFLogxK

U2 - 10.1093/ecco-jcc/jjab167

DO - 10.1093/ecco-jcc/jjab167

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.editorial???

C2 - 34626174

AN - SCOPUS:85130001373

SN - 1873-9946

VL - 16

SP - 517

JO - Journal of Crohn's and Colitis

JF - Journal of Crohn's and Colitis

IS - 4

ER -

Anti-TNF Therapy During the SARS-CoV-2 Pandemic: Friend or Foe?

UN SDGs

Access to Document

Other files and links

Cite this